Paragon Bioservices, Inc.
Erica Chacon is currently working at Catalent Pharma Solutions as an Associate Director since October 2020. Prior to that, Erica held the position of Senior Manager in Purchasing/Procurement at Paragon Bioservices, Inc. since February 1998. Erica also has experience as a Senior Manager in Procurement at Catalent MD- Paragon Gene Therapy since February 1998.
This person is not in the org chart
This person is not in any teams
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.